Abstract
IgA nephropathy (IgAN) is the most common pattern of glomerulonephritis in many parts of the world and remains an important cause of chronic kidney disease and end stage renal failure. Much progress has been made in our understanding of the genetic and biochemical pathogenic basis of the disease. The Oxford classification, a histopathology scoring system developed for IgAN in 2009, is also now widely validated and adopted. Current treatment of IgAN remains generic to many chronic kidney diseases and glomerulonephritides, while optimal treatment strategies and emerging therapeutic approaches are continually being developed and tested in clinical trials. IgA vasculitis (or Henoch-Schönlein purpura) is a systemic form of vasculitis involving the kidney, gut, skin. and joints but shares many distinct clinical features with IgAN in its kidney involvement.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: National Kidney Foundation's Primer on Kidney Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
